Benefits of stroke treatment using a mobile stroke unit compared with standard management: The BEST-MSU study run-in phase

Stroke

Volumn 46, Issue 12, 2015, Pages 3370-3374

  Bowry, Ritvij ^a   Parker, Stephanie ^a   Rajan, Suja S ^a   Yamal, Jose Miguel ^a   Wu, Tzu Ching ^a   Richardson, Laura ^b   Noser, Elizabeth ^a   Persse, David ^a   Jackson, Kamilah ^a   Grotta, James C ^c  

^a Frazer Ltd   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c MEMORIAL HERMANN HOSPITAL   (United States)

Author keywords

ambulances; emergency medical services; stroke; telemedicine; tissue type plasminogen activator

Indexed keywords

ALTEPLASE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EMERGENCY HEALTH SERVICE; EMERGENCY WARD; FEMALE; HOSPITAL PERSONNEL; HUMAN; MALE; MIDDLE AGED; MOBILE STROKE UNIT; MULTICENTER STUDY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROLOGIC EXAMINATION; NURSE; PATIENT CARE; PATIENT SELECTION; PHYSICIAN; PRIORITY JOURNAL; SEIZURE; STROKE PATIENT; STROKE UNIT; TELEMEDICINE; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION; AGED; COMPARATIVE STUDY; DISEASE MANAGEMENT; PREVENTIVE HEALTH SERVICE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; STROKE; TREATMENT OUTCOME; UNITED STATES; UTILIZATION;

AGED; DISEASE MANAGEMENT; FEMALE; HUMANS; MALE; MIDDLE AGED; MOBILE HEALTH UNITS; STROKE; TELEMEDICINE; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; UNITED STATES;

EID: 84948114840     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.115.011093     Document Type: Article

References (24)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995 333 1581 1587
2. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, ATLANTIS Trials Investigators; ECASS Trials Investigators; NINDS rt-PA Study Group Investigators Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004 363 768 774. doi: 10.1016/S0140-6736(04)15692-4.
3. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010 375 1695 1703. doi: 10.1016/S0140-6736(10)60491-6.
4. Marler JR, Tilley BC, Lu M, Brott TG, Lyden PC, Grotta JC, Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology 2000 55 1649 1655
5. Lansberg MG, Schrooten M, Bluhmki E, Thijs VN, Saver JL., Treatment time-specific number needed to treat estimates for tissue plasminogen activator therapy in acute stroke based on shifts over the entire range of the modified Rankin Scale. Stroke 2009 40 2079 2084. doi: 10.1161/STROKEAHA.108.540708.
6. Saver JL, Fonarow GC, Smith EE, Reeves MJ, Grau-Sepulveda MV, Pan W, Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA 2013 309 2480 2488. doi: 10.1001/jama.2013.6959.
7. Fonarow GC, Smith EE, Saver JL, Reeves MJ, Bhatt DL, Grau-Sepulveda MV, Timeliness of tissue-Dype plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-Do-needle times within 60 minutes. Circulation 2011 123 750 758. doi: 10.1161/CIRCULATIONAHA.110.974675.
8. Walter S, Kostopoulos P, Haass A, Keller I, Lesmeister M, Schlechtriemen T, Diagnosis and treatment of patients with stroke in a mobile stroke unit versus in hospital: a randomised controlled trial. Lancet Neurol 2012 11 397 404. doi: 10.1016/S1474-4422(12)70057-1.
9. Ebinger M, Winter B, Wendt M, Weber JE, Waldschmidt C, Rozanski M, STEMO Consortium Effect of the use of ambulance-based thrombolysis on time to thrombolysis in acute ischemic stroke: a randomized clinical trial. JAMA 2014 311 1622 1631. doi: 10.1001/jama.2014.2850.
10. Parker SA, Bowry R, Wu TC, Noser EA, Jackson K, Richardson L, Establishing the first mobile stroke unit in the United States. Stroke 2015 46 1384 1391. doi: 10.1161/STROKEAHA.114.007993.
11. Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013 44 870 947. doi: 10.1161/STR.0b013e318284056a.
12. Meretoja A, Weir L, Ugalde M, Yassi N, Yan B, Hand P, Helsinki model cut stroke thrombolysis delays to 25 minutes in Melbourne in only 4 months. Neurology 2013 81 1071 1076. doi: 10.1212/WNL.0b013e3182a4a4d2.
13. Quinn TJ, Dawson J, Walters MR, Lees KR., Functional outcome measures in contemporary stroke trials. Int J Stroke 2009 4 200 205. doi: 10.1111/j.1747-4949.2009.00271.x.
14. Chaisinanunkul N, Adeoye O, Lewis RJ, Grotta JC, Broderick J, Jovin TG, DAWN Trial and MOST Trial Steering Committees; Additional contributors from DAWN Trial Steering Committee Adopting a Patient-Centered Approach to Primary Outcome Analysis of Acute Stroke Trials Using a Utility-Weighted Modified Rankin Scale. Stroke 2015 46 2238 2243. doi: 10.1161/STROKEAHA.114.008547.
15. Wu TC, Nguyen C, Ankrom C, Yang J, Persse D, Vahidy F, Prehospital utility of rapid stroke evaluation using in-Ambulance telemedicine: a pilot feasibility study. Stroke 2014 45 2342 2347. doi: 10.1161/STROKEAHA.114.005193.
16. Hemphill JC 3rd, Greenberg SM, Anderson CS, Becker K, Bendok BR, Cushman M, American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2015 46 2032 2060. doi: 10.1161/STR.0000000000000069.
17. Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Tanaka R., Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke 1998 29 1160 1166
18. Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L, Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997 28 1 5
19. Broderick JP, Diringer MN, Hill MD, Brun NC, Mayer SA, Steiner T, Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators Determinants of intracerebral hemorrhage growth: an exploratory analysis. Stroke 2007 38 1072 1075. doi: 10.1161/01.STR.0000258078.35316.30.
20. Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, MR CLEAN Investigators A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015 372 11 20. doi: 10.1056/NEJMoa1411587.
21. Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, ESCAPE Trial Investigators Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015 372 1019 1030. doi: 10.1056/NEJMoa1414905.
22. Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, EXTEND-IA Investigators Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 2015 372 1009 1018. doi: 10.1056/NEJMoa1414792.
23. Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A, REVASCAT Trial Investigators Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 2015 372 2296 2306. doi: 10.1056/NEJMoa1503780.
24. Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, SWIFT PRIME Investigators Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 2015 372 2285 2295. doi: 10.1056/NEJMoa1415061.